A conversation between Charles Koch Foundation’s Executive Director Ryan Stowers and Mark Thain, Americas Head of Citizenship at Barclays, regarding their partnership with Per Scholas. Per Scholas has ...
Too often, high-performing individual contributors are promoted into people management roles with no preparation. They’re handed a new job that requires a completely different skillset than the one ...
In my earlier post, How to define your ideal embedded build system, we discussed build systems and how important it is to define your modern embedded build system. A build system forms the foundation ...
Elite distance runners are experts in preparation. With months-long, meticulously designed training plans, workout assessments that log weather conditions and muscle ailments, and top-to-bottom ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Internship programs might be one of the best talent investments your company will ever make. A recent survey led by the National Association of Colleges and Employers (NACE) shows that 80% of ...
As firms grow, they need to move their sales pipeline from inside their head into a more formal process, says Sarah Dobek of Inovautus Consulting, to gather the right data and hold everyone involved ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
We all want great ideas, but few understand how great ideas are born. Innovation is not an event, a workshop, a sprint, or a hackathon. It’s a result of mastering ideaflow, a practice that elevates ...
The standard American football field is 360 feet long, including the end zones. Think about standing at one end and looking down the field. Now add an extra 140 feet to your mental picture — another ...
Moderna had a challenging 2023 as demand for its COVID-19 vaccines declined, but it still expects reasonable revenue in 2024. The company has a strong pipeline of products, including respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback